# BioActor

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioactor

- Industry: Biotechnology
- Headquarters: Maastricht, Netherlands
- Website: www.bio-actor.com
- Total disclosed funding: $2.8M
- Latest round: Series A (Jul 25, 2011)
- Investors on record: 3

## About

BioActor is a Dutch company focused on creating innovative bioactive ingredients and functional food products, enhancing health and wellness through its specialized offerings.Founded in 2005 in Maastricht, Netherlands, BioActor develops bioactive ingredients for health-focused food applications. The company operates independently and has completed four deals, with its latest funding round being a Series A of EUR 2.000 mn on January 12, 2023, led by ICOS Capital. Hans van der Saag serves as both the Founder and CEO, steering the company towards growth and innovation in the nutrition sector.Bio-Actor specializes in developing and distributing bioactive ingredients and functional food products aimed at improving nutritional profiles and health benefits. Their offerings target heart health, digestive health, and overall wellness, serving food manufacturers, dietary supplement companies, and health-focused retailers in Europe, North America, and parts of Asia.Bio-Actor generates revenue through B2B transactions with food and supplement manufacturers who utilize its bioactive ingredients. This revenue model includes direct sales and long-term supply contracts, with premium pricing for flagship products due to their health benefits, typically involving bulk orders to provide clients with competitive rates.Following a majority stake acquisition by Solabia S.A.S. in January 2023, BioActor plans to enhance its R&D and product development efforts. The company aims to expand its market presence and production capabilities to meet the growing global demand for its offerings. The recent funding will facilitate the development of new products and entry into additional markets, aligning with the objectives of Solabia S.A.S. to strengthen its nutrition market position.

## Funding rounds

- Series A, Jul 25, 2011, $2.8M — Brightlands Venture Partners, ICOS Capital, Nedermaas High Tech Ventures

## Investors

- Brightlands Venture Partners (https://capitalatlas.ai/funds/brightlands-venture-partners) — Series A
- ICOS Capital (https://capitalatlas.ai/funds/icos-capital) — Series A
- Nedermaas High Tech Ventures (https://capitalatlas.ai/funds/nedermaas-high-tech-ventures) — Series A